Will the Trump administration be a game-changer for the FDA? This webinar will explore the implications of the Trump Administration and President Trump’s pick of Tom Price as Secretary of Health & Human Services on the future of the FDA. The webinar will also cover Trump’s deregulation task force at federal agencies and his federal hiring freeze. Trump’s new pick for commissioner of the FDA will be discussed as well as Trump’s intention to ease drug regulations and streamline the agency and the drug approval process. Implications for FDA regulated industries will be covered. References will be provided to documents cited.
Session Highlights:
President Trump’s vow to overhaul the FDA
Trump’s intention to upend and streamline the drug approval process
HHS head Tom Price and past policies that he has supported as well as his intentions for HHS programs
An analysis of Dr. Scott Gottlieb, Trump’s new pick for FDA commissioner
Potential risks of deregulation for drugs and other FDA regulated products
Industry reactions to Trump’s call to cut regulations & cut HHS budget
Why You Should Attend:
The Trump administration policies, potential regulatory changes, and budget cuts will have major implications for FDA regulated industries.
Who Should Attend:
Regulatory Affairs managers & directors
Medical Affairs managers & directors
Compliance specialists
Marketing managers
Anyone involved in marketing prescription drugs and OTC drugs, medical devices orf foods in the U.S. (Drug companies, medical device, consumer healthcare, and Biotech firms)
You may ask your Question directly to our expert during the Q&A session.
** You can buy On-Demand and view it at your convenience.
Norma Skolnik
Norma Skolnik is currently a Regulatory Consultant with over 35 years of regulatory experience working with the pharmaceutical and dietary supplement industries. She was Director of Regulatory Affairs for the Americas for Cadbury Adams and Director of Regulatory Affairs for the Adams division of Pfizer before that. Prior to that she was Associate Director of Regulatory Affairs for the Warner-Lambert company and Associate Director Regulatory Affairs at American Home Products Whitehall-Robbins Division.